Hematology
Steven Treon, Md, PhD
Director, Bing Center for Waldenstrom's Macroglobulinemia Research; Robert F. Tannenhauser Chair; Professor of Medicine, Harvard Medical School
Boston, MA
Dr. Steven Treon is a physician at Dana-Farber Cancer Institute specializing in Waldenström’s Macroglobulinemia, serving as Director of the Bing Center for Waldenström's Macroglobulinemia Research and an attending physician for medical oncology at Dana-Farber Cancer Institute and B; Chair for Waldenström’s Research, an Associate Professor of Medicine at Harvard Medical School in Boston, and is the Chair of the Waldenström's Macroglobul.
30+
Years in Practice
Credentials
Board Certifications
- Internal Medicine (American Board of Internal Medicine, 1995)
- Medical Oncology (American Board of Internal Medicine, 1997)
Education & Training
- PhD: Boston University (Tumor Immunology)
- Medical School: Boston University School of Medicine (MD)
- Residency: Boston University Medical Center (Internal Medicine)
- Fellowship: Massachusetts General Hospital (Hematology & Oncology)
- Research Fellowship: Dana-Farber Cancer Institute / Harvard Medical School
Peer Recognition
- Robert A. Kyle Award — Robert A. Kyle Award for Waldenstrom's Macroglobulinemia
Clinical Focus
Subspecialties
Hematology & Oncology
Conditions & Treatments
Chronic Lymphocytic LeukemiaChronic Myeloid LeukemiaLymphomaMultiple MyelomaWaldenstrom Macroglobulinemia
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
Experience
30+ years in practice